Timothy Fenske

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Adaptive Biotechnologies
    Topic:
    MRD
    Date added:
    08/21/2023
    Date updated:
    08/21/2023
    Relationship end date:
    04/01/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Astrazeneca
    Topic:
    CLL
    Date added:
    08/21/2023
    Date updated:
    08/21/2023
    Relationship end date:
    12/31/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Beigene
    Topic:
    CLL and MCL
    Date added:
    08/21/2023
    Date updated:
    08/21/2023
    Relationship end date:
    12/31/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Kite (Gilead)
    Topic:
    CAR T therapy
    Date added:
    08/21/2023
    Date updated:
    08/21/2023
    Relationship end date:
    12/31/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Lilly/Loxo
    Topic:
    BTK inhibitors
    Date added:
    08/21/2023
    Date updated:
    08/21/2023
    Relationship end date:
    12/31/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    MorphoSys
    Topic:
    DLBCL
    Date added:
    08/21/2023
    Date updated:
    08/21/2023
    Relationship end date:
    01/30/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    AbbVie
    Topic:
    ibrutinib
    Date added:
    08/21/2023
    Date updated:
    08/21/2023
    Relationship end date:
    10/31/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Sanofi
    Topic:
    BMT
    Date added:
    08/21/2023
    Date updated:
    08/21/2023
    Relationship end date:
    02/01/2023
Return to 2024 Wisconsin Multiple Myeloma & Lymphoma Summit